LBRX (STOCKS)
LB Pharmaceuticals Inc Common Stock
$25.430000
+1.090000 (+4.48%)
Prev close: $24.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Heather D. Turner
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $728.91M
- Employees
- 27
- P/E (TTM)
- —
- P/B (TTM)
- 2.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.45 | $-0.46 | +0.0065 | +1.42% |
|
Sep 2025 (Q3)
|
$-0.61 | $-0.46 | -0.1459 | -31.44% |
Financial Statements
| Nonoperating Income/Loss | $5.20M |
| Operating Expenses | $30.40M |
| Depreciation and Amortization | $300.00K |
| Research and Development | $16.74M |
| Other Operating Expenses | $13.36M |
| Income/Loss From Continuing Operations After Tax | -$25.21M |
| Income/Loss From Continuing Operations Before Tax | -$25.20M |
| Income Tax Expense/Benefit | $1.00K |
| Income Tax Expense/Benefit, Current | $1.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$25.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$25.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.21K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$25.18M |
| Preferred Stock Dividends And Other Adjustments | -$25.18M |
| Basic Earnings Per Share | -$3.13 |
| Diluted Earnings Per Share | -$3.13 |
| Basic Average Shares | 8,045,145 |
| Diluted Average Shares | 8,045,145 |
| Assets | $312.93M |
| Current Assets | $308.43M |
| Cash | $295.20M |
| Other Current Assets | $13.23M |
| Noncurrent Assets | $4.50M |
| Fixed Assets | $1.58M |
| Other Non-current Assets | $2.92M |
| Liabilities | $11.62M |
| Current Liabilities | $7.44M |
| Accounts Payable | $2.13M |
| Other Current Liabilities | $5.32M |
| Noncurrent Liabilities | $4.18M |
| Equity | $301.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $301.31M |
| Liabilities And Equity | $312.93M |
| Net Cash Flow From Operating Activities | -$35.21M |
| Net Cash Flow From Operating Activities, Continuing | -$35.21M |
| Net Cash Flow From Investing Activities | -$39.89M |
| Net Cash Flow From Investing Activities, Continuing | -$39.89M |
| Net Cash Flow From Financing Activities | $302.56M |
| Net Cash Flow From Financing Activities, Continuing | $302.56M |
| Net Cash Flow | $227.47M |
| Net Cash Flow, Continuing | $227.47M |
| Comprehensive Income/Loss | -$25.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.15M |
| Other Comprehensive Income/Loss | -$25.15M |